CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,783,029 | +6.8% | 152,526 | +22.8% | 0.00% | 0.0% |
| Q2 2023 | $1,669,234 | -3.6% | 124,199 | +18.9% | 0.00% | 0.0% |
| Q1 2023 | $1,731,433 | -10.5% | 104,429 | +0.4% | 0.00% | 0.0% |
| Q4 2022 | $1,935,051 | +11.0% | 104,035 | -23.5% | 0.00% | 0.0% |
| Q3 2022 | $1,744,000 | +82.4% | 135,968 | -0.3% | 0.00% | – |
| Q2 2022 | $956,000 | +121.3% | 136,350 | +161.8% | 0.00% | – |
| Q1 2022 | $432,000 | -91.7% | 52,088 | -97.6% | 0.00% | -100.0% |
| Q4 2015 | $5,211,000 | -18.3% | 2,127,100 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $6,381,000 | -38.5% | 2,127,100 | -15.3% | 0.00% | -40.0% |
| Q2 2015 | $10,373,000 | -4.6% | 2,511,600 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $10,875,000 | +45.8% | 2,511,600 | 0.0% | 0.01% | +66.7% |
| Q4 2014 | $7,459,000 | -10.6% | 2,511,600 | 0.0% | 0.00% | -25.0% |
| Q3 2014 | $8,339,000 | +27.3% | 2,511,600 | -3.0% | 0.00% | +33.3% |
| Q2 2014 | $6,551,000 | – | 2,589,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |